These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23351745)

  • 1. G protein-coupled receptor heterodimerization in the brain.
    Borroto-Escuela DO; Romero-Fernandez W; Garriga P; Ciruela F; Narvaez M; Tarakanov AO; Palkovits M; Agnati LF; Fuxe K
    Methods Enzymol; 2013; 521():281-94. PubMed ID: 23351745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing world of G protein-coupled receptors: from monomers to dimers and receptor mosaics with allosteric receptor-receptor interactions.
    Fuxe K; Marcellino D; Borroto-Escuela DO; Frankowska M; Ferraro L; Guidolin D; Ciruela F; Agnati LF
    J Recept Signal Transduct Res; 2010 Oct; 30(5):272-83. PubMed ID: 20684666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental strategies for studying G protein-coupled receptor homo- and heteromerization with radioligand binding and signal transduction methods.
    Maggio R; Rocchi C; Scarselli M
    Methods Enzymol; 2013; 521():295-310. PubMed ID: 23351746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of GPCR/ion channel interactions.
    Altier C; Zamponi GW
    Methods Mol Biol; 2011; 756():215-25. PubMed ID: 21870228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moonlighting characteristics of G protein-coupled receptors: focus on receptor heteromers and relevance for neurodegeneration.
    Borroto-Escuela DO; Tarakanov AO; Guidolin D; Ciruela F; Agnati LF; Fuxe K
    IUBMB Life; 2011 Jul; 63(7):463-72. PubMed ID: 21698749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bimolecular fluorescence complementation analysis of G protein-coupled receptor dimerization in living cells.
    Ejendal KF; Conley JM; Hu CD; Watts VJ
    Methods Enzymol; 2013; 521():259-79. PubMed ID: 23351744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis.
    Fuxe K; Marcellino D; Leo G; Agnati LF
    Curr Opin Pharmacol; 2010 Feb; 10(1):14-22. PubMed ID: 19942481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPCR oligomerization and receptor trafficking.
    Ward RJ; Xu TR; Milligan G
    Methods Enzymol; 2013; 521():69-90. PubMed ID: 23351734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History and biological significance of GPCR heteromerization in the neuroendocrine system.
    Tadagaki K; Jockers R; Kamal M
    Neuroendocrinology; 2012; 95(3):223-31. PubMed ID: 22156565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligomerization of GPCRs involved in endocrine regulation.
    Kleinau G; Müller A; Biebermann H
    J Mol Endocrinol; 2016 Jul; 57(1):R59-80. PubMed ID: 27151573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 induces G-protein-coupled receptor heteromer formation.
    Schelshorn D; Joly F; Mutel S; Hampe C; Breton B; Mutel V; Lütjens R
    Mol Pharmacol; 2012 Mar; 81(3):309-18. PubMed ID: 22108912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPCR heteromers and their allosteric receptor-receptor interactions.
    Fuxe K; Borroto-Escuela DO; Marcellino D; Romero-Fernandez W; Frankowska M; Guidolin D; Filip M; Ferraro L; Woods AS; Tarakanov A; Ciruela F; Agnati LF; Tanganelli S
    Curr Med Chem; 2012; 19(3):356-63. PubMed ID: 22335512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to G protein-coupled receptor oligomerization.
    Comps-Agrar L; Maurel D; Rondard P; Pin JP; Trinquet E; Prézeau L
    Methods Mol Biol; 2011; 756():201-14. PubMed ID: 21870227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterodimerization of g protein-coupled receptors: specificity and functional significance.
    Prinster SC; Hague C; Hall RA
    Pharmacol Rev; 2005 Sep; 57(3):289-98. PubMed ID: 16109836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein-coupled receptor oligomerization for what?
    Ciruela F; Vallano A; Arnau JM; Sánchez S; Borroto-Escuela DO; Agnati LF; Fuxe K; Fernández-Dueñas V
    J Recept Signal Transduct Res; 2010 Oct; 30(5):322-30. PubMed ID: 20718634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.
    Ferré S; Casadó V; Devi LA; Filizola M; Jockers R; Lohse MJ; Milligan G; Pin JP; Guitart X
    Pharmacol Rev; 2014; 66(2):413-34. PubMed ID: 24515647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional crosstalk between GPCRs: with or without oligomerization.
    Prezeau L; Rives ML; Comps-Agrar L; Maurel D; Kniazeff J; Pin JP
    Curr Opin Pharmacol; 2010 Feb; 10(1):6-13. PubMed ID: 19962942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoting neurotrophic effects by GPCR ligands.
    Jeanneteau F; Chao MV
    Novartis Found Symp; 2006; 276():181-9; discussion 189-92, 233-7, 275-81. PubMed ID: 16805430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Receptor Heteromerization Using In Situ Proximity Ligation Assay.
    Gomes I; Sierra S; Devi LA
    Curr Protoc Pharmacol; 2016 Dec; 75():2.16.1-2.16.31. PubMed ID: 27960030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-protein-coupled receptor type A heteromers as an emerging therapeutic target.
    Guidolin D; Agnati LF; Marcoli M; Borroto-Escuela DO; Fuxe K
    Expert Opin Ther Targets; 2015 Feb; 19(2):265-83. PubMed ID: 25381716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.